Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.

Fauchier L, Greenlaw N, Ferrari R, Ford I, Fox KM, Tardif JC, Tendera M, Steg PG; CLARIFY Investigators.

PLoS One. 2015 Apr 27;10(4):e0125164. doi: 10.1371/journal.pone.0125164. eCollection 2015.

2.

Assessment of mineral elements and heavy metals in leaves of indigenous cypress of High Atlas Mountains.

Arjouni MY, Bennouna MA, El Fels MA, Romane A.

Nat Prod Res. 2015;29(8):764-7. doi: 10.1080/14786419.2014.974052. Epub 2014 Nov 25.

PMID:
25421148
3.

Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients.

Kalra PR, García-Moll X, Zamorano J, Kalra PA, Fox KM, Ford I, Ferrari R, Tardif JC, Tendera M, Greenlaw N, Steg PG; CLARIFY Investigators.

PLoS One. 2014 Jul 22;9(7):e102335. doi: 10.1371/journal.pone.0102335. eCollection 2014.

4.

Effects of chronic and acute lead treatments on the biophysical properties of erythrocyte membranes, and a comparison with model membranes.

Ahyayauch H, Sansar W, Rendón-Ramírez A, Goñi FM, Bennouna M, Gamrani H.

FEBS Open Bio. 2013 Apr 15;3:212-7. doi: 10.1016/j.fob.2013.04.001. Print 2013.

5.

Improvement of therapeutic compliance in haemodialysis patients with poor phosphorus control and adherence to treatment with binders: COMQUELFOS study.

Dolores Arenas M, Pérez-García R, Bennouna M, Blanco A, Mauricio O, Prados MD, Lerma JL, Luisa Muñiz M, Belén Martín M; Estudio COMQUELFOS.

Nefrologia. 2013;33(2):196-203. doi: 10.3265/Nefrologia.pre2012.Oct.11726. Epub 2013 Jan 6. English, Spanish.

6.

Quantitative analysis of some oligo-elements and heavy metals in some species of Thymus from Morocco.

Bennouna MA, Belaqziz R, Arjouni MY, Romane A.

Nat Prod Res. 2013;27(19):1784-8. doi: 10.1080/14786419.2012.751597. Epub 2012 Dec 13.

PMID:
23234338
7.

Chronic renal dysfunction in kidney transplant recipients. Consensus Document. Spanish Consensus Group on Renal Dysfunction in Kidney Transplantation Patients.

Pascual J, Alonso A, Burgos D, Cruzado JM, Serón D; Grupo Español de Consenso sobre disfunción renal crónica en pacientes.

Nefrologia. 2012;32 Suppl 2:1-28. doi: 10.3265/Nefrologia.pre2012.Mar.11433. English, Spanish. No abstract available.

8.

Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.

Steg PG, Ferrari R, Ford I, Greenlaw N, Tardif JC, Tendera M, Abergel H, Fox KM; CLARIFY Investigators.

PLoS One. 2012;7(5):e36284. doi: 10.1371/journal.pone.0036284. Epub 2012 May 3.

9.

["Horseshoe kidney", renal adenocarcinoma and nephrotic syndrome].

Rivera F, Caparrós G, Vozmediano C, Bennouna M, Anaya S, Sánchez de la Nieta MD, García Rojo M, Blanco J.

Nefrologia. 2010;30(5):596-8. doi: 10.3265/Nefrologia.pre2010.Jul.10550. Review. Spanish. No abstract available.

10.
11.

[The shadow of "RALES" is long].

Pereira E, Carreño A, Bennouna M, Ferreras I.

Aten Primaria. 2010 Sep;42(9):487-8. doi: 10.1016/j.aprim.2009.10.024. Epub 2010 Feb 2. Spanish. No abstract available.

12.

[Enema in a patient with renal failure: a cause of severe hyperphosphatemia].

Bennouna M, Anaya S, Sánchez de la Nieta MD, Rivera F.

Nefrologia. 2008;28(6):657-9. Spanish. No abstract available.

13.

[Cholinergic hypothesis in psychosis following traumatic brain injury and cholinergic hypothesis in schizophrenia: a link?].

Bennouna M, Greene VB, Defranoux L.

Encephale. 2007 Sep;33(4 Pt 1):616-20. Review. French.

PMID:
18033152
14.

Changes in erythrocyte morphology induced by imipramine and chlorpromazine.

Ahyayaucha H, Gallego M, Casis O, Bennouna M.

J Physiol Biochem. 2006 Sep;62(3):199-205.

PMID:
17451161
15.

Adjuvant galantamine to risperidone improves negative and cognitive symptoms in a patient presenting with schizophrenialike psychosis after traumatic brain injury.

Bennouna M, Greene VB, Defranoux L.

J Clin Psychopharmacol. 2005 Oct;25(5):505-7. No abstract available.

PMID:
16160637
16.

Interaction of electrically neutral and cationic forms of imipramine with liposome and erythrocyte membranes.

Ahyayauch H, Goñi FM, Bennouna M.

Int J Pharm. 2004 Jul 26;279(1-2):51-8.

PMID:
15234794
17.

pH-dependent effects of chlorpromazine on liposomes and erythrocyte membranes.

Ahyayauch H, Goñi FM, Bennouna M.

J Liposome Res. 2003 May;13(2):147-55.

PMID:
12855109
18.

Surfactant effects of chlorpromazine and imipramine on lipid bilayers containing sphingomyelin and cholesterol.

Ahyayauch H, Requero MA, Alonso A, Bennouna M, Goñi FM.

J Colloid Interface Sci. 2002 Dec 15;256(2):284-9.

PMID:
12573633
19.

Interaction of chlorpromazine and imipramine with model membranes.

Ahyayauch H, Bennouna M.

Therapie. 1999 Sep-Oct;54(5):585-8.

PMID:
10667094
20.

Lipid-Drug Interaction and Colligative Properties in Phospholipid Vesicles.

Banerjee S, Bennouna M, Ferreira-Marques J, Ruysschaert JM, Caspers J.

J Colloid Interface Sci. 1999 Nov 1;219(1):168-177.

PMID:
10527584

Supplemental Content

Loading ...
Support Center